Literature DB >> 27759477

Equilibrative nucleoside transporters-A review.

Rebba C Boswell-Casteel1, Franklin A Hays1,2,3.   

Abstract

Equilibrative nucleoside transporters (ENTs) are polytopic integral membrane proteins that mediate the transport of nucleosides, nucleobases, and therapeutic analogs. The best-characterized ENTs are the human transporters hENT1 and hENT2. However, non-mammalian eukaryotic ENTs have also been studied (e.g., yeast, parasitic protozoa). ENTs are major pharmaceutical targets responsible for modulating the efficacy of more than 30 approved drugs. However, the molecular mechanisms and chemical determinants of ENT-mediated substrate recognition, binding, inhibition, and transport are poorly understood. This review highlights findings on the characterization of ENTs by surveying studies on genetics, permeant and inhibitor interactions, mutagenesis, and structural models of ENT function.

Entities:  

Keywords:  Nucleoside transport; equilibrative nucleoside transporter; membrane protein; nucleobase transport

Mesh:

Substances:

Year:  2016        PMID: 27759477      PMCID: PMC5728162          DOI: 10.1080/15257770.2016.1210805

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  181 in total

1.  Natural variation in human membrane transporter genes reveals evolutionary and functional constraints.

Authors:  Maya K Leabman; Conrad C Huang; Joseph DeYoung; Elaine J Carlson; Travis R Taylor; Melanie de la Cruz; Susan J Johns; Doug Stryke; Michiko Kawamoto; Thomas J Urban; Deanna L Kroetz; Thomas E Ferrin; Andrew G Clark; Neil Risch; Ira Herskowitz; Kathleen M Giacomini
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

2.  Ethanol metabolism and inhibition of nucleoside uptake lead to increased extracellular adenosine in hepatocytes.

Authors:  L E Nagy
Journal:  Am J Physiol       Date:  1992-05

3.  Penetrating eye injuries in rural New South Wales.

Authors:  C G Thompson; R K Griffits; W Nardi; M P Tester; M J Noble; L Cottee; P Weir
Journal:  Aust N Z J Ophthalmol       Date:  1997-02

4.  Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).

Authors:  M F Vickers; R S Mani; M Sundaram; D L Hogue; J D Young; S A Baldwin; C E Cass
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

5.  The Equilibrative Nucleoside Transporter (ENT1) can be phosphorylated at multiple sites by PKC and PKA.

Authors:  German Reyes; Nicole M I Nivillac; Muhammad Zia Karim; Leroi Desouza; K W Michael Siu; Imogen R Coe
Journal:  Mol Membr Biol       Date:  2011-08-02       Impact factor: 2.857

Review 6.  Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells.

Authors:  Ying Huang; Wolfgang Sadée
Journal:  Cancer Lett       Date:  2005-10-05       Impact factor: 8.679

7.  Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition.

Authors:  Isabelle Melki; Karen Lambot; Laurence Jonard; Vincent Couloigner; Pierre Quartier; Bénédicte Neven; Brigitte Bader-Meunier
Journal:  Pediatrics       Date:  2013-03-25       Impact factor: 7.124

Review 8.  Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

Authors:  Lars Petter Jordheim; David Durantel; Fabien Zoulim; Charles Dumontet
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

9.  HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia.

Authors:  Holger K Eltzschig; Parween Abdulla; Edgar Hoffman; Kathryn E Hamilton; Dionne Daniels; Caroline Schönfeld; Michaela Löffler; German Reyes; Michael Duszenko; Jorn Karhausen; Andreas Robinson; Karen A Westerman; Imogen R Coe; Sean P Colgan
Journal:  J Exp Med       Date:  2005-12-05       Impact factor: 14.307

Review 10.  Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.

Authors:  Marçal Pastor-Anglada; Sandra Pérez-Torras
Journal:  Front Pharmacol       Date:  2015-02-10       Impact factor: 5.810

View more
  55 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 2.  Epilepsy and astrocyte energy metabolism.

Authors:  Detlev Boison; Christian Steinhäuser
Journal:  Glia       Date:  2017-10-17       Impact factor: 7.452

3.  Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.

Authors:  Siennah R Miller; Raymond K Hau; Joseph L Jilek; Mark N Morales; Stephen H Wright; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2020-05-11       Impact factor: 3.922

Review 4.  A guide to plasma membrane solute carrier proteins.

Authors:  Mattia D Pizzagalli; Ariel Bensimon; Giulio Superti-Furga
Journal:  FEBS J       Date:  2020-09-18       Impact factor: 5.542

Review 5.  Adenosine Metabolism: Emerging Concepts for Cancer Therapy.

Authors:  Detlev Boison; Gennady G Yegutkin
Journal:  Cancer Cell       Date:  2019-12-09       Impact factor: 31.743

Review 6.  Adenosine and the Cardiovascular System.

Authors:  Allison B Reiss; David Grossfeld; Lora J Kasselman; Heather A Renna; Nicholas A Vernice; Wendy Drewes; Justin Konig; Steven E Carsons; Joshua DeLeon
Journal:  Am J Cardiovasc Drugs       Date:  2019-10       Impact factor: 3.571

7.  Plasma and cerebrospinal fluid pharmacokinetics of the DNA methyltransferase inhibitor, 5-azacytidine, alone and with inulin, in nonhuman primate models.

Authors:  Cynthia Lester McCully; Louis T Rodgers; Rafael Cruz; Marvin L Thomas; Cody J Peer; William D Figg; Katherine E Warren
Journal:  Neurooncol Adv       Date:  2020-01-01

8.  Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.

Authors:  Siennah R Miller; Xiaohong Zhang; Raymond K Hau; Joseph L Jilek; Erin Q Jennings; James J Galligan; Daniel H Foil; Kimberley M Zorn; Sean Ekins; Stephen H Wright; Nathan J Cherrington
Journal:  Mol Pharmacol       Date:  2020-12-01       Impact factor: 4.436

9.  Low oxygen tension differentially regulates the expression of placental solute carriers and ABC transporters.

Authors:  Ludwik Gorczyca; Jianyao Du; Kristin M Bircsak; Xia Wen; Anna M Vetrano; Lauren M Aleksunes
Journal:  FEBS Lett       Date:  2020-10-07       Impact factor: 4.124

10.  The Structure and Mechanism of Drug Transporters.

Authors:  Arthur G Roberts
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.